CD8A and X-linked lymphoproliferative syndrome: Remarkably, pharmacological inhibition of DGKα partially restored RICD sensitivity in XLP-1 patient effector T cells, and markedly reduced CD8+ T cell accumulation and overt immunopathology in Sap-deficient mice infected with LCMV (Ruffo et al., 2016).